 Agile Therapeutics, Inc. NASDAQ:AGRX Q2 2022 Results Conference Call August 11, 2022 4:30 PM ET Company Participants Matt Riley - Head, IR Al Altomari - Chairman and CEO Amy Welsh - VP, Marketing Conference Call Participants Oren Livnat - H.C. Wainright Operator Good afternoon, and welcome to the Agile Therapeutics Second Quarter 2022 Financial Results Conference Call. 